SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lorus Therapeutics LORFF LOR

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mark calgary who wrote ()1/6/2000 11:09:00 PM
From: Frank Moss   of 101
 
Strategic Partner & News Imminent!!!!!!!!!!
Quoting Mr. Lacaille, "seek out a strategic partner to help bring Virulizin to market. By filing for a NEW drug submission in Canada,....would allow the company to market Virulizin without waiting for the ...completion of the Phase 111 trials." end quote.
He also said that the three small molecule compounds were a "multi-billion dollar potential." The world is watching...and buying. Every major/minor institution, drug company, mutual fund, insurance company(big time-they want a cure), competitor, and Research facility want a piece of the action. And what about every family in the world that is effected by cancer as potential investors. Some are saying LOR is the next blockbuster Pharmaceutical Company----in a very short period of time.
Think obout it! A Cancer treatment/cure-Yahoo's price would be about right. And God bless these cancer victims--hope LOR comes through for you.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext